Granules shares gain over 5% on U.S. FDA nod for ADHD generic capsules
Granules India receives FDA approval for generic ADHD drug, expanding portfolio and reinforcing presence in treatment space.
Daily19h
Granules India arm gets USFDA nod for ADHD drug Lisdexamfetamine Dimesylate
Hyderabad: Granules India Limited, a vertically integrated Indian pharmaceutical company, has announced that its wholly-owned ...
Granules India gets USFDA’s nod for ADHD generic
Granules India's subsidiary, GPI, receives USFDA approval for Lisdexamfetamine Dimesylate Capsules, expanding ADHD treatment ...
Pharmabiz17h
Granules strengthens ADHD portfolio with US FDA approval for lisdexamfetamine dimesylate capsules
Granules strengthens ADHD portfolio with US FDA approval for lisdexamfetamine dimesylate capsules: Our Bureau, Bengaluru Thursday, January 30, 2025, 16:15 Hrs [IST] Granules India ...
SW Londoner15h
NHS wait times for people with eating disorders hit ‘crisis’ levels
Demand for access to NHS services for those with eating disorders has reached record highs, statistics from NHS Digital show.
newsdrum20h
Granules India gets USFDA nod for attention deficit hyperactivity disorder treatment capsules
Pharmaceuticals firm, Granules India Ltd on Thursday said its arm has received a final nod from the US health regulator for its generic version of ...
Investing12h
Indian stock market continues winning streak ahead of Union Budget
On January 29, the foreign institutional investors (FIIs) remained net sellers for the 19th consecutive session as they sold equities worth Rs 2,586 crore, while domestic institutional investors ...
I’m a size 24 and she’s a size 12 – being fat shouldn’t change how you dress
Unless you’ve been hiding under a rock for the past decade you’ll be aware that Britain has an obesity problem. Two-thirds of ...